| ADVANCED MIC.DEV. DL-,01 | 26.965 / +1.47% |
| Date/Time | 10/14 / 17:05 |
| Chg. / Chg.(%) | 0.390 / +1.47% |
| Bid | 27.185 / 920 |
| Ask | 27.285 / 920 |
| Open | 27.205 |
| Previous Close | 26.575 |
| High | 27.205 |
| Low | 26.840 |
| Volume [EUR] | 0.000 |
| Volume [Units] | 0 |
| Price fixings | 4 |
| ISIN | US0079031078 |
| Security | AMD |
| Exchange | Düsseldorf |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| NASDAQ | 30.0150 |  |
17,119,179 |
| Cboe US | 30.02 | |
833,924 |
| IEX | 30.19 |  |
264,188 |
| London Inter.. | 29.96 | |
49,374 |
| Xetra | 27.130 | |
31,004 |
| TradeGate | 27.450 | |
24,084 |
| Borsa Italia.. | 26.965 | |
1,900 |
| Frankfurt | 26.8950 | |
1,406 |
| Stuttgart | 27.125 | |
700 |
| Vienna Globa.. | 27.07 | |
470 |
| München | 27.180 | |
285 |
| gettex | 27.095 | |
30 |
| Berlin | 26.690 | |
22 |
| Hannover | 27.205 | |
0 |
| Hamburg | 27.205 | |
0 |
| Düsseldorf | 26.965 | |
0 |
| Lang & Schwa.. | 27.190 | |
|
| Mexico | 571.00 | |
7,450 |
| SIX Swiss Ex.. | 25.590 | ||
| SIX Swiss Ex.. | 27.000 | ||
| Borsa Italia.. | 24.900 |  |
69 |
News
- Opthea Presents Additional Data from OPT-302 Phase 2b Wet AMD Trial at the Ophthalmology Innovation Summit in San Francisco
11:30 - GlobeNewswire - Adverum Biotechnologies Reports Additional Clinical Data from First Cohort of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD at the American Academy of Ophthalmology 2019 Annual Meeting
10/12/2019 / 01:26 - GlobeNewswire - Wall Street starts higher on fresh hopes of trade breakthrough
10/09/2019 / 15:30 - TeleTrader - Galimedix Therapeutics, Inc. To Present at Ophthalmology Innovation Summit During the American Academy of Ophthalmology Meeting
10/08/2019 / 15:35 - GlobeNewswire - ONL Therapeutics Announces First-In-Human Clinical Study with ONL1204
10/08/2019 / 13:00 - GlobeNewswire
Real-time